IMUX
Immunic Inc
9.30$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -18.9% | +91.8% | -17.0% | -25.1% | -36.9% | -49.8% | +199.4% | -33.7% | -40.9% | +688.9% | -16.1% | |
| – | -19.5% | +95.3% | -17.2% | -25.6% | -37.8% | -51.8% | +215.4% | -34.4% | -41.8% | +725.4% | -16.4% | |
| – | -21.8% | +108.5% | -18.1% | -25.9% | -39.6% | -59.9% | +286.7% | -36.5% | -55.9% | +1,105.4% | -16.9% | |
| – | -21.8% | +108.5% | -18.1% | -25.9% | -39.6% | -59.9% | +286.7% | -36.5% | -55.9% | +1,105.4% | -16.9% | |
| – | -40.8% | +105.7% | +3.9% | -45.5% | -16.5% | -7.7% | -5.9% | -70.2% | +2,228.8% | -91.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +36.6% | -18.9% | +11.4% | +2.7% | -4.7% | +15.0% | +6.7% | +9.8% | +1.7% | +25.3% | -18.0% | |
| – | +39.1% | -18.5% | +12.6% | +3.0% | -5.1% | +15.4% | +6.7% | +10.1% | +1.8% | +25.3% | -18.5% | |
| – | +5.0% | +0.3% | +2.4% | -0.1% | +3.8% | +3.4% | +1.2% | -14.0% | -29.4% | -41.5% | -13.1% | |
| – | +59.4% | +21.8% | +22.4% | -23.9% | +35.5% | -29.8% | +43.3% | -6.9% | +38.0% | +3.7% | +20.5% | |
| – | -40.2% | +188.9% | -23.9% | -35.2% | -55.3% | -128.7% | – | -69.0% | -163.6% | – | -15.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +118.0% | +4.1% | +0.0% | -11.0% | +12.4% | +30.4% | +46.7% | -37.9% | +150.3% | +41.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.